Page last updated: 2024-08-26

1,4-dihydropyridine and Pituitary Neoplasms

1,4-dihydropyridine has been researched along with Pituitary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arnoux, A; Cannon, R; Hammond, C; Kordon, C; Kwiecien, R; Robert, C; Vigues, S1

Other Studies

1 other study(ies) available for 1,4-dihydropyridine and Pituitary Neoplasms

ArticleYear
Endogenous pacemaker activity of rat tumour somatotrophs.
    The Journal of physiology, 1998, May-01, Volume: 508 ( Pt 3)

    Topics: Action Potentials; Animals; Antisense Elements (Genetics); Apamin; Barium; Biological Clocks; Cadmium; Calcium; Calcium Channel Blockers; Calcium Channels; Charybdotoxin; Computer Simulation; Cytosol; Dihydropyridines; Growth Hormone; Growth Hormone-Releasing Hormone; Nickel; Nifedipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; Patch-Clamp Techniques; Peptides; Pituitary Neoplasms; Potassium; Rats; Ryanodine Receptor Calcium Release Channel; Sodium; Spider Venoms; Tetraethylammonium; Tetrodotoxin; Tumor Cells, Cultured

1998